5070Riociguat in transthyretin cardiac amyloidosis-data from a named patient use program in austria. (28th August 2018) - Duca, F; Aschauer, S; Zotter-Tufaro, C; Binder, C; Kammerlander, A A; Boerries, B; Agis, H; Kain, R; Mascherbauer, J; Bonderman, D